6.82
6.82 (0%)
As of Apr 17, 2025
Inogen Inc [INGN]
Source:
Company Overview
Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment.
| Country | United States |
| Headquarters | goleta, california |
| Phone Number | 805-562-0500 |
| Industry | manufacturing |
| CEO | Kevin R. M. Smith |
| Website | www.inogen.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $335.7 |
| Operating Profit | $-42.5 |
| Net Income | $-35.9 |
| Net Cash | $-8.1 |
Profit Ratios
| Gross Margin | $154.7 |
| Operating Margin | -12.7 |
| Profit as % of Revenues | -431.2% |
| Profit as % of Assets | -11.5% |
| Profit as % of Stockholder Equity | -20.6% |
Management Effectiveness
| Return on Equity | -20.6% |
| Return on Assets | -12.1% |
| Turnover Ratio | 107.9% |
| EBITA | $-42.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $296.2 |
| Total Liabilities | $122.3 |
| Operating Cash Flow | $5.9 |
| Investing Cash Flow | $-14 |
| Financing Cash Flow | $0.3 |
